The leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM Pharma for TL 4.2 billion (USD 530 million), making it […]
Read moreThe leading Turkish pharmaceutical company Abdi Ibrahim purchased 28.5 per cent of the shares of the Swiss biotech company OM Pharma for TL 4.2 billion (USD 530 million), making it […]
Read moreGive us a call or drop by anytime, we endeavour to answer all enquiries within 24 hours on business days.